Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrity Laboratories provides high-complexity clinical diagnostic services with a focus on rapid molecular detection of infectious diseases. Their proprietary Intercept PCR™ platform enables same-day or next-day results with high specificity (>99%) across a broad range of viral and bacterial targets. They have validated tests for SARS-CoV‑2, Influenza A/B, RSV A/B (via RespiPlex AIO), and Monkeypox virus among others. The company emphasizes antimicrobial stewardship by providing actionable data to guide targeted therapy decisions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integrity Laboratories.